Really disturbing piece on Merck’s promoting of Vioxx, downplaying the heart risks. A shame. I used to think Merck was one of the more ethical of the drug companies.
A drug’s ability to prevent or cure or slow the progress of disease should stand on its own, not on $2,000 sales bonuses. [via DB's MedRants]
This is a medical weblog--a collection of thoughts about medicine, medical training, and health policy--written by a fifth-year medical student.
I recently stopped blogging, as I graduated from medical school and I'm now a physician in my residency training in New York City. But feel free to read and enjoy!
(To get rid of this thing, just wave your mouse over it. Ta da!
Down and Dirty Merck
Click through for the full piece on Merck:…